IPOL
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
50090-1693 -
Package NDC
50090-1693-9 -
Application number
BLA103930 -
SPL ID
e37ce631-105e-4efa-8a0f-b2e107fb5252
What the source publishes
- Labeler
- A-S Medication Solutions
- Active ingredients
- POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
- Form
- INJECTION, SUSPENSION
- Routes
- INTRAMUSCULAR
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- VACCINE
Names this record is found by
- IPOL
- POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
- POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)
- POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)
- POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)
Complete source data
{
"name": "IPOL",
"splId": "e37ce631-105e-4efa-8a0f-b2e107fb5252",
"labels": [],
"routes": [
"INTRAMUSCULAR"
],
"labeler": "A-S Medication Solutions",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, MULTI-DOSE in 1 PACKAGE (50090-1693-9) / 5 mL in 1 VIAL, MULTI-DOSE (50090-1693-0)",
"package_ndc": "50090-1693-9",
"identifierStatus": "well-formed",
"marketing_start_date": "19901221"
}
],
"productId": "50090-1693_e37ce631-105e-4efa-8a0f-b2e107fb5252",
"useDomain": "unknown",
"dosageForm": "INJECTION, SUSPENSION",
"productNdc": "50090-1693",
"deaSchedule": null,
"genericName": "POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED), POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED), and POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)",
"productType": "VACCINE",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)",
"strength": "40 [D'ag'U]/.5mL"
},
{
"name": "POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)",
"strength": "8 [D'ag'U]/.5mL"
},
{
"name": "POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)",
"strength": "32 [D'ag'U]/.5mL"
}
],
"applicationNumber": "BLA103930",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "19901221",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "unknown",
"harmonizedIdentifiers": {},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:50090-1693_e37ce631-105e-4efa-8a0f-b2e107fb5252"